Thermal ablation in cancer (Review)

Liu,Yong; Cao,Cheng-Song; Yu,Yang; Si,Ya-Meng

doi:10.3892/ol.2016.4997

Thermal ablation in cancer (Review)

Authors:
- Yong Liu
- Cheng-Song Cao
- Yang Yu
- Ya-Meng Si
View Affiliations

Affiliations: Department of Internal Medicine-Oncology, Xuzhou Central Hospital, Xuzhou, Jiangsu 221009, P.R. China, Department of Oral and Maxillofacial Surgery, Xuzhou Central Hospital, Xuzhou, Jiangsu 221009, P.R. China
Published online on: August 11, 2016 https://doi.org/10.3892/ol.2016.4997
Pages: 2293-2295
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Radiofrequency ablation (RFA) and cryoablation are alternative forms of therapy used widely in various pathological states, including treatment of carcinogenesis. The reason is that ablation techniques have ability of modulating the immune system. Furthermore, recent studies have applied this form of therapy on tumor microenvironment and in the systematic circulation. Moreover, RFA and cryoablation result in an inflammatory immune response along with tissue disruption. Evidence has demonstrated that these procedures affect carcinogenesis by causing a significant local inflammatory response leading to an immunogenic gene signature. The present review enlightens the current view of these techniques in cancer.

View Figures

View References

1	Voigt JD and Barnett G: The value of using a brain laser interstitial thermal therapy (LITT) system in patients presenting with high grade gliomas where maximal safe resection may not be feasible. Cost Eff Resour Alloc. 14:62016. View Article : Google Scholar : PubMed/NCBI
2	Alblin RJ, Soanes WA and Gonder MJ: Prospects for cryo-immunotherapy in cases of metastasizing carcinoma of the prostate. Cryobiology. 8:271–279. 1971. View Article : Google Scholar : PubMed/NCBI
3	Suzuki Y: Cryosurgical treatment of advanced breast cancer and cryoimmunological responses. Skin Cancer. 10:19–26. 1995.
4	Sabel MS: Cryo-immunology: a review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses. Cryobiology. 58:1–11. 2009. View Article : Google Scholar : PubMed/NCBI
5	Gallucci S, Lolkema M and Matzinger P: Natural adjuvants: endogenous activators of dendritic cells. Nat Med. 5:1249–1255. 1999. View Article : Google Scholar : PubMed/NCBI
6	Reiter I, Krammer B and Schwamberger G: Cutting edge: differential effect of apoptotic versus necrotic tumor cells on macrophage antitumor activities. J Immunol. 163:1730–1732. 1999.PubMed/NCBI
7	Sauter B, Albert ML, Francisco L, Larsson M, Somersan S and Bhardwaj N: Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med. 191:423–434. 2000. View Article : Google Scholar : PubMed/NCBI
8	Matzinger P: Tolerance, danger, and the extended family. Annu Rev Immunol. 12:991–1045. 1994. View Article : Google Scholar : PubMed/NCBI
9	Shi Y, Evans JE and Rock KL: Molecular identification of a danger signal that alerts the immune system to dying cells. Nature. 425:516–521. 2003. View Article : Google Scholar : PubMed/NCBI
10	Scaffidi P, Misteli T and Bianchi ME: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 418:191–195. 2002. View Article : Google Scholar : PubMed/NCBI
11	Scheffer SR Sr, Nave H, Korangy F, Schlote K, Pabst R, Jaffee EM, Manns MP and Greten TF: Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo. Int J Cancer. 103:205–211. 2003. View Article : Google Scholar : PubMed/NCBI
12	Kotera Y, Shimizu K and Mulé JJ: Comparative analysis of necrotic and apoptotic tumor cells as a source of antigen(s) in dendritic cell-based immunization. Cancer Res. 61:8105–8109. 2001.PubMed/NCBI
13	Gamrekelashvili J, Krüger C, von Wasielewski R, Hoffmann M, Huster KM, Busch DH, Manns MP, Korangy F and Greten TF: Necrotic tumor cell death in vivo impairs tumor-specific immune responses. J Immunol. 178:1573–1580. 2007. View Article : Google Scholar : PubMed/NCBI
14	Feng H, Zeng Y, Graner MW and Katsanis E: Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cells. Blood. 100:4108–4115. 2002. View Article : Google Scholar : PubMed/NCBI
15	Kolischer G: Surgical diathermy in malignancy. Am J Surg. 7:249–250. 1929. View Article : Google Scholar
16	McGahan JP, Brock JM, Tesluk H, Gu WZ, Schneider P and Browning PD: Hepatic ablation with use of radio-frequency electrocautery in the animal model. J Vasc Interv Radiol. 3:291–297. 1992. View Article : Google Scholar : PubMed/NCBI
17	Wissniowski TT, Hänsler J, Neureiter D, Frieser M, Schaber S, Esslinger B, Voll R, Strobel D, Hahn EG and Schuppan D: Activation of tumor-specific T lymphocytes by radio-frequency ablation of the VX2 hepatoma in rabbits. Cancer Res. 63:6496–6500. 2003.PubMed/NCBI
18	denBrok MH, Sutmuller RP, van der Voort R, Bennink EJ, Figdor CG, Ruers TJ and Adema GJ: In situ tumor ablation creates an antigen source for the generation of antitumor immunity. Cancer Res. 64:4024–4029. 2004. View Article : Google Scholar : PubMed/NCBI
19	Dromi SA, Walsh MP, Herby S, Traughber B, Xie J, Sharma KV, Sekhar KP, Luk A, Liewehr DJ, Dreher MR, et al: Radiofrequency ablation induces antigen-presenting cell infiltration and amplification of weak tumor-induced immunity. Radiology. 251:58–66. 2009. View Article : Google Scholar : PubMed/NCBI
20	Napoletano C, Taurino F, Biffoni M, De Majo A, Coscarella G, Bellati F, Rahimi H, Pauselli S, Pellicciotta I, Burchell JM, et al: RFA strongly modulates the immune system and anti-tumor immune responses in metastatic liver patients. Int J Oncol. 32:481–490. 2008.PubMed/NCBI
21	Hansler J, Wissniowski TT, Schuppan D, Witte A, Bernatik T, Hahn EG and Strobel D: Activation and dramatically increased cytolytic activity of tumor specific T lymphocytes after radio-frequency ablation in patients with hepatocellular carcinoma and colorectal liver metastases. World J Gastroenterol. 12:3716–3721. 2006. View Article : Google Scholar : PubMed/NCBI
22	Zerbini A, Pilli M, Penna A, Pelosi G, Schianchi C, Molinari A, Schivazappa S, Zibera C, Fagnoni FF, Ferrari C, et al: Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses. Cancer Res. 66:1139–1146. 2006. View Article : Google Scholar : PubMed/NCBI
23	Zerbini A, Pilli M, Fagnoni F, Pelosi G, Pizzi MG, Schivazappa S, Laccabue D, Cavallo C, Schianchi C, Ferrari C, et al: Increased immunostimulatory activity conferred to antigen-presenting cells by exposure to antigen extract from hepatocellular carcinoma after radiofrequency thermal ablation. J Immunother. 31:271–282. 2008. View Article : Google Scholar : PubMed/NCBI
24	Sidana A, Chowdhury WH, Fuchs EJ and Rodriguez R: Cryoimmunotherapy in urologic oncology. Urology. 75:1009–1014. 2010. View Article : Google Scholar : PubMed/NCBI
25	Myers RS, Hammond WG and Ketcham AS: Tumor-specific transplantation immunity after cryosurgery. J Surg Oncol. 1:241–246. 1969. View Article : Google Scholar : PubMed/NCBI
26	Blackwood CE and Cooper IS: Response of experimental tumor systems to cryosurgery. Cryobiology. 9:508–515. 1972. View Article : Google Scholar : PubMed/NCBI
27	Neel HB III, Ketcham AS and Hammond WG: Experimental evaluation of in situ oncocide for primary tumor therapy: comparison of tumor-specific immunity after complete excision, cryonecrosis and ligation. Laryngoscope. 83:376–387. 1973. View Article : Google Scholar : PubMed/NCBI